Cancerous inhibitor of protein phosphatase 2A was upregulated and was negatively proportional to clinically prognostic features in various types of cancer, including CRC (Bockelman et al., 2011; Dong et al., 2011; Liu et al., 2014; Teng et al., 2012). Here, CIP2A is linked to cancer.